If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInforma Regulatory News (INF)

Share Price Information for Informa (INF)

Share Price is delayed by 15 minutes
Get Live Data
916.60    1.40 (0.15%)
Bid:
915.40
Ask:
916.00
Spread: 0.60 (0.066%)
Market Cap: £11.49b
INF Live PriceLast checked at - London Stock Exchange

Intraday Informa Share Chart

Transaction in Own Shares

25 Jul 2023 07:00

RNS Number : 0237H
Informa PLC
25 July 2023
 

Informa PLC Press Release

24 July 2023

Informa Share Buyback Programme

Update on GAP 2 shareholder returns

Informa (LSE: INF.L), the international Academic Markets, B2B Markets and Digital Services Group today provided an update on its Share Buyback Programme that forms part of the 2021-2024 Growth Acceleration Plan 2 ('GAP 2').

Share Buyback Programme

GAP 2 is Informa's four-year programme to create a more focused, higher growth business. This includes accelerated investment in its two businesses with scale leadership positions, B2B Markets and Academic Markets, and the divestment of its Informa Intelligence portfolio of businesses.

GAP 2 also includes a commitment to accelerate shareholder returns, sharing some of the divestment proceeds with shareholders, alongside increased investment into the Group's two leadership businesses. This led to the resumption of ordinary dividends and a £1bn Share Buyback Programme.

As part of this Share Buyback, on 21 July 2023, the Company purchased 179,128 ordinary shares for cancellation through Morgan Stanley & Co. International plc at an average price of 749.63 pence per share. The highest and lowest purchase price paid per share were 749.80 and 748.80 respectively, with the aggregate details of shares purchased by trading venue as outlined in the table below:

Trading venue

Weighted average price paid per share (GBp)

Aggregate number of shares purchased

Lowest price paid per share(GBp)

Highest price paid per share(GBp)

London Stock Exchange

749.60

105,792

748.80

749.80

Chi-X (CXE)

749.69

51,725

749.00

749.80

BATS (BXE)

749.68

18,882

749.20

749.80

AQUIS (AQXE)

749.53

2,729

748.80

749.80

Following settlement of the above purchases and cancellation of the purchased ordinary shares, the Company's total number of ordinary shares in issue, and its total voting rights, will be 1,398,308,280 ordinary shares. The Company does not hold any shares in Treasury.

In accordance with Article 5(1)(b) of the Market Abuse Regulation, a full breakdown of the individual trades made as part of the buyback programme is detailed in the attachment.

http://www.rns-pdf.londonstockexchange.com/rns/0237H_1-2023-7-24.pdf

Enquiries

Richard Menzies-Gow, Director of IR & Communications

+44 (0) 20 8052 2787

Heledd Hanscomb, Deputy Company Secretary

+44 (0) 20 8052 0661

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSBRGDRGUDDGXS
Date   Source Headline
14th Apr 202310:45 amRNSHolding(s) in Company
14th Apr 20237:00 amRNSTransaction in Own Shares
13th Apr 20237:00 amRNSTransaction in Own Shares
12th Apr 202310:05 amRNSListing Application
12th Apr 20237:00 amRNSTransaction in Own Shares
11th Apr 20237:00 amRNSTransaction in Own Shares
6th Apr 20237:00 amRNSTransaction in Own Shares
5th Apr 20237:00 amRNSTransaction in Own Shares
4th Apr 20237:00 amRNSTransaction in Own Shares
3rd Apr 202311:19 amRNSTotal Voting Rights
3rd Apr 20237:00 amRNSTransaction in Own Shares
31st Mar 20237:00 amRNSTransaction in Own Shares
30th Mar 20237:00 amRNSTransaction in Own Shares
29th Mar 20234:54 pmRNSShare option exercise and sale to cover
29th Mar 20237:00 amRNSTransaction in Own Shares
28th Mar 202311:15 amRNSHolding(s) in Company
28th Mar 20237:00 amRNSTransaction in Own Shares
27th Mar 20237:00 amRNSTransaction in Own Shares
24th Mar 20237:00 amRNSTransaction in Own Shares
23rd Mar 20237:00 amRNSTransaction in Own Shares
22nd Mar 20234:00 pmRNSHolding(s) in Company
22nd Mar 20237:00 amRNSTransaction in Own Shares
21st Mar 20231:01 pmRNSHolding(s) in Company
21st Mar 20237:00 amRNSTransaction in Own Shares
20th Mar 20232:29 pmRNSHolding(s) in Company
20th Mar 20232:25 pmRNSHolding(s) in Company
20th Mar 20237:00 amRNSTransaction in Own Shares
17th Mar 20237:00 amRNSTransaction in Own Shares
16th Mar 20238:59 amRNSHolding(s) in Company
16th Mar 20237:00 amRNSTransaction in Own Shares
15th Mar 20231:54 pmRNSDirector's Purchase of Shares
15th Mar 20237:00 amRNSTransaction in Own Shares
14th Mar 20237:00 amRNSTransaction in Own Shares
13th Mar 20237:00 amRNSTransaction in Own Shares
10th Mar 20237:00 amRNSTransaction in Own Shares
9th Mar 20237:25 amRNSTransaction in Own Shares
9th Mar 20237:00 amRNSAcquisition of Tarsus
9th Mar 20237:00 amRNS2022 Full-Year Results
8th Mar 20237:00 amRNSTransaction in Own Shares
7th Mar 20237:00 amRNSTransaction in Own Shares
6th Mar 20237:00 amRNSTransaction in Own Shares
3rd Mar 20239:34 amRNSHolding(s) in Company
3rd Mar 20237:00 amRNSTransaction in Own Shares
2nd Mar 20237:00 amRNSTransaction in Own Shares
1st Mar 202311:18 amRNSTotal Voting Rights
1st Mar 20237:00 amRNSTransaction in Own Shares
28th Feb 20237:00 amRNSTransaction in Own Shares
27th Feb 20239:50 amRNSHolding(s) in Company
27th Feb 20237:00 amRNSTransaction in Own Shares
24th Feb 20237:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.